HemoGenyx Pharmaceuticals Plc (HOPHF)
2.33
0.00 (0.00%)
USD |
OTCM |
Oct 16, 16:00
HemoGenyx Pharmaceuticals Net Income (TTM) : -15.20M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -15.20M |
| December 31, 2025 | -12.87M |
| June 30, 2025 | -10.12M |
| December 31, 2024 | -7.188M |
| June 30, 2024 | -6.534M |
| December 31, 2023 | -8.305M |
| June 30, 2023 | -8.673M |
| December 31, 2022 | -4.821M |
| Date | Value |
|---|---|
| June 30, 2022 | -3.491M |
| December 31, 2021 | -7.056M |
| June 30, 2021 | -6.689M |
| December 31, 2020 | -2.697M |
| June 30, 2020 | -1.991M |
| December 31, 2019 | -1.854M |
| June 30, 2019 | -1.989M |
| December 31, 2018 | -1.965M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Silence Therapeutics Plc | -59.95M |
| Biodexa Pharmaceuticals Plc | -5.93M |
| NuCana Plc | -13.03M |
| Mereo BioPharma Group Plc | -28.05M |
| Compass Pathways Plc | -407.35M |